New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 17, 2012
10:27 EDTSJM, VLO, HFC, RP, ITRI, MHS, UPL, AIMC, ARTC, JWN, ACOR, HSP, MXWL, DELLOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: Dell (DELL) downgraded to Neutral from Outperform at RW Baird...Maxwell Tech (MXWL) downgraded to Neutral from Outperform at RW Baird...Hospira (HSP) downgraded to Sell from Neutral at Citigroup...Acorda Therapeutics (ACOR) downgraded to Neutral from Buy at Citigroup...Nordstrom (JWN) downgraded to Underperform from Buy at CLSA...ArthroCare (ARTC) downgraded to Hold from Buy at Jefferies...Altra Holdings (AIMC) downgraded to Hold from Buy at Jefferies...Ultra Petroleum (UPL) downgraded to Hold from Buy at Jefferies...Medco Health (MHS) downgraded to Equal Weight from Overweight at Morgan Stanley...Itron (ITRI) downgraded to Hold from Buy at KeyBanc...RealPage (RP) downgraded to Sector Perform from Outperform at Pacific Crest...HollyFrontier (HFC) downgraded to Neutral from Buy at UBS...Valero Energy (VLO) downgraded to Neutral from Buy at UBS...J.M. Smucker (SJM) downgraded to Buy from Conviction Buy at Goldman.
News For DELL;MXWL;HSP;ACOR;JWN;ARTC;AIMC;UPL;MHS;ITRI;RP;HFC;VLO;SJM From The Last 14 Days
Check below for free stories on DELL;MXWL;HSP;ACOR;JWN;ARTC;AIMC;UPL;MHS;ITRI;RP;HFC;VLO;SJM the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
April 22, 2014
09:22 EDTMXWLMaxwell initiated with a Buy at Sidoti
Subscribe for More Information
07:45 EDTVLOValero downgraded to Neutral from Buy at BofA/Merrill
Subscribe for More Information
07:37 EDTVLO, HFCIncreased refiner exporting playing a role in high gas prices, WSJ says
Gasoline futures climbed a bit over 1% a gallon Monday and are up 11% for the year. While gasoline prices often rise ahead of summer, more gasoline being exported by refiners plays a "prominent" role in the current rally, said The Wall Street Journal, citing analysts. Publicly traded refiners include HollyFrontier (HFC), Marathon Oil (MRO), Phillips 66 (PSX), Tesoro (TSO), Valero (VLO) and Western Refining (WNR). Reference Link
April 21, 2014
11:31 EDTMXWLMaxwell rally could be due to 'bullish' article, says Piper Jaffray
Subscribe for More Information
10:01 EDTHFCOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
08:41 EDTHFCHollyFrontier downgraded to Sector Perform from Outperform at Howard Weil
Subscribe for More Information
April 19, 2014
20:42 EDTHSPHospira, Orion sue Akorn to halt generic launch of Precedex, Bloomberg says
Hospira and Finnish drug company Orion Oyj have accused Akorn of infringing on the patent for the sedative Precedex, says Bloomberg.
April 17, 2014
09:59 EDTACOROn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: AcelRx (ACRX) initiated with a Buy at Canaccord... Acorda Therapeutics (ACOR) initiated with a Hold at Canaccord... Alcobra (ADHD) initiated with a Buy at Canaccord... Benefitfocus (BNFT) initiated with a Market Perform at William Blair... Cameron (CAM) initiated with a Buy at Gabelli... Covanta (CVA) initiated with an Outperform at Macquarie... Foundation Medicine (FMI) initiated with a Market Perform at William Blair... Golub Capital (GBDC) initiated with an Outperform at Raymond James... Hanmi Financial (HAFC) initiated with an Outperform at Raymond James... Jazz Pharmaceuticals (JAZZ) initiated with a Buy at Canaccord... Kronos Worldwide (KRO) initiated with a Reduce at SunTrust... Magnum Hunter (MHR) initiated with a Hold at Maxim... Norwegian Cruise Line (NCLH) initiated with a Buy at Longbow... Plum Creek Timber (PCL) initiated with an Outperform at RBC Capital... RF Micro Devices (RFMD) initiated with a Market Perform at BMO Capital... SanDisk (SNDK) assumed with an Overweight at Piper Jaffray... Skyworks (SWKS) initiated with a Market Perform at BMO Capital... TransEnterix (TRXC) initiated with a Buy at Sterne Agee... TriQuint (TQNT) initiated with a Market Perform at BMO Capital... WebMD (WBMD) initiated with an Outperform at William Blair.
07:31 EDTACORAcorda Therapeutics initiated with a Hold at Canaccord
Subscribe for More Information
April 16, 2014
10:00 EDTHSPOn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: A10 Networks (ATEN) initiated with a Buy at BofA/Merrill... Actavis (ACT) initiated with a Buy at Sterne Agee... Allergan (AGN) initiated with a Buy at Sterne Agee... Autohome (ATHM) initiated with a Neutral at Credit Suisse... BitAuto (BITA) initiated with an Outperform at Credit Suisse... Centene (CNC) initiated with a Neutral at UBS... Endo International (ENDP) initiated with a Buy at Sterne Agee... FS Investment (FSIC) initiated with an Overweight at Evercore... Hertz (HTZ) initiated with a Buy at Gabelli... Hilton (HLT) initiated with a Hold at Jefferies... Hospira (HSP) initiated with a Neutral at Sterne Agee... ImmunoGen (IMGN) initiated with a Buy at Canaccord... Impax (IPXL) initiated with a Neutral at Sterne Agee... Imperva (IMPV) assumed with a Neutral at Wedbush... Ingredion (INGR) initiated with an Outperform at Credit Suisse... Laredo Petroleum (LPI) initiated with an Outperform at RW Baird... Lpath (LPTN) initiated with a Buy at Canaccord... MediWound (MDWD) initiated with an Outperform at Oppenheimer... Medivation (MDVN) initiated with a Hold at Canaccord... NPS Pharmaceuticals (NPSP) assumed with a Buy at Canaccord... Nimble Storage (NMBL) initiated with a Market Perform at Raymond James... Regeneron (REGN) initiated with a Buy at Canaccord... Salix (SLXP) initiated with a Buy at Sterne Agee... Sibanye Gold (SBGL) initiated with an Outperform at Imperial Capital... Teva (TEVA) initiated with a Neutral at Sterne Agee... Wipro (WIT) assumed with a Hold at Jefferies.
07:59 EDTHSPHospira initiated with a Neutral at Sterne Agee
Subscribe for More Information
April 14, 2014
10:02 EDTACOROn The Fly: Analyst Upgrade Summary
Acorda Therapeutics (ACOR) upgraded to Outperform from Market Perform at FBR Capital... Allegheny Technologies (ATI) upgraded to Neutral from Underperform at Sterne Agee... BP (BP) upgraded to Buy from Hold at Canaccord... Bloomin' Brands (BLMN) upgraded to Buy from Hold at Deutsche Bank... Boardwalk Pipeline (BWP) upgraded to Neutral from Underperform at BofA/Merrill... Boston Scientific (BSX) upgraded at BofA/Merrill... Charles Schwab (SCHW) upgraded to Buy from Neutral at UBS... Citigroup (C) upgraded to Hold from Sell at Rafferty Capital... Community Health (CYH) upgraded to Outperform from Perform at Oppenheimer... Eaton Vance (EV) upgraded to Neutral from Sell at Citigroup... Eli Lilly (LLY) upgraded to Hold from Underperform at Jefferies... F5 Networks (FFIV) upgraded to Buy from Hold at Stifel... HeartWare (HTWR) upgraded to Buy from Neutral at BTIG... Heartland Payment (HPY) upgraded to Hold from Sell at Stifel... Hyatt Hotels (H) upgraded to Outperform from Market Perform at FBR Capital... MasterCard (MA) upgraded to Outperform from Neutral at RW Baird... McDermott (MDR) upgraded to Neutral from Underweight at HSBC... Palo Alto (PANW) upgraded to Overweight at Stephens... PetroChina (PTR) upgraded to Neutral from Underperform at Credit Suisse... Seagate (STX) upgraded to Buy from Hold at Argus... Sensata (ST) upgraded to Buy from Neutral at Citigroup... Stryker (SYK) upgraded to Neutral from Reduce at SunTrust... TD Ameritrade (AMTD) upgraded to Buy from Neutral at UBS... TTM Technologies (TTMI) upgraded to Buy from Hold at Stifel... Transocean (RIG) upgraded to Hold from Sell at Deutsche Bank... VMware (VMW) upgraded to Outperform from Underperform at CLSA... Visa (V) upgraded to Outperform from Neutral at RW Baird... Yahoo (YHOO) upgraded to Buy from Neutral at SunTrust... Zimmer (ZMH) upgraded to Neutral from Reduce at SunTrust... bebe stores (BEBE) upgraded to Buy from Neutral at Janney Capital.
09:00 EDTACORAcorda Therapeutics falls 6.2%
Subscribe for More Information
08:59 EDTACOROn The Fly: Pre-market Movers
Subscribe for More Information
08:58 EDTACORAcorda Therapeutics delays start of Phase 3 study of dalfampridine-QD to 2H
Acorda Therapeutics announced that the initiation of its Phase 3 study of dalfampridine-QD in people with post-stroke walking deficits will begin in the second half of 2014; previously the company had projected study initiation in the second quarter of 2014. The developer of the once-daily, or QD, formulation has informed the company of an alcohol dose dumping finding in vitro and the company will need to perform a short clinical study to determine whether this also exists in vivo. The clinical study will be conducted in healthy volunteers and is expected to be completed in the third quarter of 2014, Acorda said.
07:56 EDTACORAcorda Therapeutics upgraded to Outperform from Market Perform at FBR Capital
Subscribe for More Information
06:26 EDTACORAcorda Therapeutics upgraded to Outperform from Market Perform at FBR Capital
Subscribe for More Information
April 10, 2014
09:32 EDTMXWLMaxwell rail-related opportunity underappreciated, says Piper Jaffray
Subscribe for More Information
09:29 EDTMXWLMaxwell supplying ultracapacitors to ABB for Philadelphia rail lines
Subscribe for More Information
April 9, 2014
08:24 EDTARTCPiper Jaffray's medtech analysts hold an analyst/industry conference call
The MedTech Analyst Team focuses on Piper Jaffray's covered universe from the perspective of Technical Analyst Johnson ahead of 1Q14 earnings results on an Analyst/Industry conference call to be held on April 11 at 10 am.
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use